Select Medical Holdings, Corp. (SEM)

NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04

$16.510.00%

Close 2026-07-01 · 1-day change

Standing thesis

The standing, falsifiable read: what has to stay true, and what would break it.

Special situation

Warn: Management is running behind on a stated commitment.

The bull case

Select Medical is completing a $3.9 billion acquisition in mid-2026. Revenue is expected between $5.6B and $5.8B in 2026. Earnings per share should be $1.22 to $1.32 this year. The company pays a steady dividend of $0.0625 per share.

The bear case

Revenue growth could slow below 5%. Earnings might miss the $1.22 low end. Legal or regulatory issues could arise after the merger.

What's priced in

The price is about 13% below our fair value near $19. Analysts expect about 5% revenue growth. Our view aligns with these expectations.

What has to stay true

Complete acquisition and merger by mid-2026Recovered
Management ExecutionprimaryAcquisition completed by mid-2026 · mid-2026 (qualitative)
Breaks if: Acquisition not completed by mid-2026
Are they delivering?On Track this quarter· 1 tracked commitment
- Complete acquisition and merger transaction in mid-2026Other
  Complete the merger transaction with the consortium led by Robert A. Ortenzio and WCAS by mid-2026.
  On Track

Source: QuarterlyIQ research model· Written 2026-07-08· Health checked 2026-09-04· Version 1· Status: Warn· Reviewed when the evidence changes

This is not a price target or investment advice.

Current Outlook

Week of Sep 5, 2026

A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.

SEM is navigating a strong sector backdrop with mixed management execution and a focus on maintaining guidance.

What kind of bet this is

This investment represents a durable compounder with a medium confidence level. The current thesis state is intact, supported by strong recent financial performance, although management execution has shown volatility.

What's priced into Select Medical Holdings, Corp. (SEM)

The market currently prices SEM as cheap compared to its peers, with a slight expectations gap indicating that some cautious sentiment is already reflected. There is low fragility in the stock, suggesting that it is not overly sensitive to negative news.

What the fundamentals likely do

Management is focused on maintaining revenue, EPS, and Adjusted EBITDA guidance, which is crucial for the company's performance. However, there is a near-term risk of missing earnings expectations, as SEM has a history of recent misses.

What Select Medical Holdings, Corp. (SEM) hinges on

The long-term thesis hinges on management's ability to maintain guidance and the performance of sector bellwethers. Additionally, broader economic indicators, such as job reports, will influence sentiment and performance in the healthcare sector.

What changed in the latest read

What changed

The most important moves since the prior daily snapshot.

Short-term · Daily

No material changes since the prior snapshot.

Mixed, the news cuts both ways. The company maintained its revenue guidance of $5.6B to $5.8B for 2026, which supports the outlook. However, there was a recent earnings miss, which raises concerns about performance.

as of 2026-09-04

See upcoming information that could change the risk

Review the evidence to watch, what would become a concern, and what would make it less concerning.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.